Mylan launches generic version of Sporanox

Generics |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 30 Jul, 2012

Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...Read more

Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...Read more

AstraZeneca, BMS gets FDA nod for diabetes drug

Generics |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 09 Jan, 2014

Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...Read more

Ranbaxy advisory: All our products are safe and efficacious

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...Read more

Rabies claims 100 lives annually in Vietnam: UN

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 30 Sep, 2013

Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...Read more

Now Ranbaxy's Mohali unit under FDA scanner

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...Read more

Mundipharma, Shionogi tie up for pain treatment in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Nov, 2013

Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...Read more

GSK files for approval on melanoma drug combo

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...Read more

TB prevention faces gap of $1.6bn: WHO estimates

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...Read more

Avanir Pharma settles patent litigation with Wockhardt

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...Read more

TWi Pharma gets FDA nod for ADHD drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...Read more

Sandoz launches trial with Amgen biosimilar

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...Read more

US company leverages on generics

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...Read more

NATCO wins compulsory license for anti-cancer drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...Read more

Mylan gets FDA nod for Thiamine Hydrochloride Injection

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...Read more

Big pharma to drive R&D innovation with $4.4 bn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...Read more

Multiple organzations join hands to curb fake drug business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...Read more

Arvind sets up $42.37 mn plant top tap US market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...Read more